Chemistry partner EDELRIS praises collaboration within ELF

News
29 March 2018

EDELRIS, a medicinal chemistry company, shares several LinkedIn posts explaining the key factors in the European Lead Factory that make their work possible. In their second post, EDELRIS tells more about their collaboration with the academic groups: 

As the European Lead Factory project is about to meet one of its tremendous targets, now is an excellent opportunity to look back and share the key factors that make our work possible: ● Collaboration ● Science ● Team work ● Production ● Outcomes.

We have been working in unison with 3 academic groups, all of us proposing and validating the synthesis of new chemical scaffolds: Profs S. Marsden and A. Nelson (University of Leeds, UK) and Profs M. Clausen along with initially T. Nielsen (Technical University of Denmark). Academic groups and SMEs (Small and Medium-sized Enterprises) working together: Complexity vs chemical accessibility.

Timelines are of the utmost importance and delivering compounds at such a demanding pace required open communication with our academic partners. Understanding and pooling our individual objectives towards a common goal was key to our success: Reducing the synthetic steps to effectively produce compounds while maintaining complexity and originality, with the support of Lead Discovery Center.

Our interactions spread beyond this partnership and included developing a macrocyclic scaffold from Dr W. Unsworth (University of York, UK) and sharing expertise with the other SME partners.

Read EDELRIS' LinkedIn post here